Dr. Adam Byrne is originally from St. John’s, Newfoundland, where he graduated from Memorial University with a M.Sc. in Biochemistry. He worked on several research projects afterwards, including the metabolism of adipose tissue at Memorial University before moving to novel detection of HPV infection at Newfoundland Public Health Labs. He returned to medical school at Memorial University before completing his Pediatrics residency at the University of Ottawa. He completed a fellowship in Pediatric Clinical Immunology and Allergy at McGill University before returning to Ottawa, where he now practices Allergy and Immunology in private practice in the community, as well as at the Children’s Hospital of Eastern Ontario, where he was the recipient of the award for clinical excellence in his first year of practice and is one of the clinical leads for the Pediatric Severe Asthma clinic. Dr. Byrne has presented national and international on a variety of topics, including severe asthma, food allergy, allergic rhinitis, idiopathic anaphylaxis, and the use of AI in healthcare settings. He is an active member of the CSACI, including co-chair of the National Residency Education Program, a member of the Committee for Professional Development, as well as a member of the Scientific Planning Committee. Dr. Byrne is a co-chair of the joint CSACI/CAR Guidance on Contrast Hypersensitivity Reactions.
COI: Dr. Adam Byrne serves as an advisory board member for ALK, AstraZeneca, Bausch Health, and Sanofi. Additionally, he has received research funding for food allergy interventions from DBV Technologies and RAPT Pharmaceuticals.